Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.

Suppr

超能文献

作者信息

GRAHAM J R

出版信息

N Engl J Med. 1960 Dec 22;263:1273-7. doi: 10.1056/NEJM196012222632502.

DOI:10.1056/NEJM196012222632502

PMID:13707731

Abstract

摘要

相似文献

Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.

N Engl J Med. 1960 Dec 22;263:1273-7. doi: 10.1056/NEJM196012222632502.

Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.

Angiology. 1960 Aug;11:364-6. doi: 10.1177/000331976001100409.

Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).

Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002.

[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].

Prog Med (Napoli). 1960 Jan 15;16:20-2.

[UML-491 (1-methyl-D-lysergic acid butanolamide) in the prevention and treatment of migraine and other types of headache].

Rev Clin Esp. 1962 Dec 15;87:273-7.

Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).

AMA Arch Neurol Psychiatry. 1958 Feb;79(2):201-7.

A new approach to the prophylactic treatment of vascular headache.

Allerg Asthma (Leipz). 1961 Sep;7:287-92.

[Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].

C R Seances Soc Biol Fil. 1960;154:2386-9.

Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.

Arch Neurol. 1961 Mar;4:235-40. doi: 10.1001/archneur.1961.00450090001001.

Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).

Proc Staff Meet Mayo Clin. 1962 Aug 15;37:433-43.

引用本文的文献

CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.

J Neurol Neurosurg Psychiatry. 1964 Oct;27(5):463-9. doi: 10.1136/jnnp.27.5.463.

NEUROGENIC INTERMITTENT CLAUDICATION.

Br Med J. 1964 Oct 17;2(5415):985-7. doi: 10.1136/bmj.2.5415.985.

METHYSERGIDE.

Br Med J. 1964 Sep 12;2(5410):677.

New concepts of the nature and treatment of migraine.

Trans Am Clin Climatol Assoc. 1961;73:199-208.

Management of trigeminal autonomic cephalgias and hemicrania continua.

Drugs. 2003;63(16):1637-77. doi: 10.2165/00003495-200363160-00002.

Research in migraine.

Br Med J. 1966 May 28;1(5499):1315-6.

Prophylaxis of recurrent headache.

Br Med J. 1969 Jan 4;1(5635):5-6.

Methysergide in prophylaxis of migraine: a clinical trial in general practice.

Br Med J. 1966 Aug 13;2(5510):394-5. doi: 10.1136/bmj.2.5510.394.

[Vasoactive substances belonging to the body and pharmacologic agents with peripheral point of application].

Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1967;188(1):84-114.

Vascular headache.

J Gen Intern Med. 1988 Jul-Aug;3(4):384-95. doi: 10.1007/BF02595799.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验